Ultragenyx Pharmaceutical, Inc. (RARE)
16.49
-0.73
(-4.24%)
USD |
NASDAQ |
Nov 20, 16:00
16.48
-0.01
(-0.06%)
After-Hours: 19:36
Ultragenyx Pharmaceutical Gross Profit (TTM) : 571.22M for Sept. 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 571.22M |
| June 30, 2026 | 562.55M |
| March 31, 2026 | 525.43M |
| December 31, 2025 | 529.07M |
| September 30, 2025 | 498.76M |
| June 30, 2025 | 485.14M |
| March 31, 2025 | 467.14M |
| December 31, 2024 | 447.96M |
| September 30, 2024 | 424.40M |
| June 30, 2024 | 401.74M |
| March 31, 2024 | 383.26M |
| December 31, 2023 | 384.50M |
| September 30, 2023 | 363.34M |
| June 30, 2023 | 354.35M |
| March 31, 2023 | 333.24M |
| December 31, 2022 | 319.99M |
| September 30, 2022 | 302.16M |
| June 30, 2022 | 298.34M |
| March 31, 2022 | 301.77M |
| December 31, 2021 | 322.16M |
| September 30, 2021 | 328.74M |
| June 30, 2021 | 330.52M |
| March 31, 2021 | 306.52M |
| December 31, 2020 | 252.64M |
| September 30, 2020 | 198.03M |
| Date | Value |
|---|---|
| June 30, 2020 | 142.97M |
| March 31, 2020 | 107.53M |
| December 31, 2019 | 86.17M |
| September 30, 2019 | 70.66M |
| June 30, 2019 | 56.82M |
| March 31, 2019 | 42.12M |
| December 31, 2018 | 30.81M |
| September 30, 2018 | 17.90M |
| June 30, 2018 | 10.76M |
| March 31, 2018 | 3.136M |
| December 31, 2017 | -2.317M |
| September 30, 2017 | -2.216M |
| June 30, 2017 | -2.216M |
| March 31, 2017 | -1.161M |
| December 31, 2016 | -0.544M |
| September 30, 2016 | -1.024M |
| June 30, 2016 | -1.465M |
| March 31, 2016 | -1.727M |
| December 31, 2015 | -1.384M |
| September 30, 2015 | -1.116M |
| June 30, 2015 | -0.869M |
| March 31, 2015 | -0.768M |
| December 31, 2014 | -0.684M |
| September 30, 2014 | -0.584M |
| June 30, 2014 | -0.495M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Ionis Pharmaceuticals, Inc. | 915.88M |
| AbbVie, Inc. | 48.66B |
| Krystal Biotech, Inc. | 437.21M |
| BridgeBio Pharma, Inc. | 890.06M |
| Alnylam Pharmaceuticals, Inc. | 3.874B |